Meridian Bioscience, Inc. Provides Sales and Earnings Guidance for Fiscal 2014 and Reaffirms Fiscal 2013 Guidance
Published: Sep 09, 2013
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2014 sales and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year ending September 30, 2014, management expects net sales to be in the range of $203 to $208 million and per share diluted earnings to be between $0.98 and $1.03.
Help employers find you! Check out all the jobs and post your resume.